国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Feline panleucopenia virus strain snow leopard; Feline rhinotracheitis virus strain FVRm; Feline calcivirus strain F9
Elanco Animal Health, Eli Lilly and Company Limited
QI06AD04
Feline panleucopenia virus strain snow leopard; Feline rhinotracheitis virus strain FVRm; Feline calcivirus strain F9
.
Lyophilisate and solvent for solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cats
feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus
Immunological - Live Vaccine
Authorised
2010-12-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT FELOCELL CVR. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml dose (when reconstituted) contains: ACTIVE SUBSTANCE(S) Live attenuated feline enteritis (panleucopenia) virus (FPV), Snow Leopard strain minimum : 10 3.0 *CCID 50 Live attenuated feline rhinotracheitis virus (FVR), strain FVRm minimum : 10 5.0 CCID 50 Live attenuated Calicivirus (FCV), strain F9 minimum : 10 5.5 CCID 50 *CCID 50 = Cell culture infectious dose EXCIPIENTS: For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Lyophilisate and solvent for solution for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats from 9 weeks of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Felocell CVR is a live attenuated vaccine designed to reduce the clinical signs of disease caused by feline enteritis (panleucopenia) virus, feline rhinotracheitis virus and calicivirus in cats. The onset of immunity is from 3 weeks post- vaccination and last_S_ for 1 year. 4.3 CONTRAINDICATIONS Unhealthy animals should not be vaccinated. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not vaccinate animals for at least one month after cessation of corticosteroid treatment. Due to the nature of post- vaccination viral shedding, it is advised that vaccinated kittens are kept away from pregnant queens for a period of three weeks. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _6_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _ 阅读完整的文件